PIEZO1 and central nervous system cancer: Notably, after 4 weeks, mice bearing PIEZO1 KO glioma xenografts exhibited a significant reduction in glioma cell proliferation rate (Fig. 5e, f) compared to those bearing PIEZO1 WT glioma cells from the same patient.